Skip to content

Clinical trials

Mastocytosis, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mastocytosis, Systemic Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20072
20082
20092
20111
20121
20132
20141
20155
20162
20183
20192
20206
20212
20222
20233
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting8
Unknown status7
Terminated4
Active, not recruiting4
Withdrawn1
Available1
Not yet recruiting1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation10
Novartis Pharmaceuticals4
Cogent Biosciences, Inc.3
Jason Robert Gotlib3
M.D. Anderson Cancer Center3
National Institute of Allergy and Infectious Diseases (NIAID)3
University Hospital, Toulouse3
AB Science2
City of Hope Medical Center2
Hospital Virgen de la Salud2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mastocytosis, Systemic53
Leukemia, Mast-Cell16
Mastocytosis16
Leukemia4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Leukemia, Myeloid, Acute4
Mastocytosis, Cutaneous4
Blastic Plasmacytoid Dendritic Cell Neoplasm3
Hematologic Neoplasms3
Leukemia, Hairy Cell3

Trials

Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.